• Title

    Probing the mysteries of human health and disease.

  • Title Slide 3

    Collaborative research environment harnessing leading-edge technology and training.

  • Title Slide 2

    Vibrant biomedical research campus situated in the beautiful Sonoran Desert Ecosystem.

  • Student Slide

    Multidisciplinary program to train the next generation of biomedical scientists.

A multidisciplinary PhD program focused on outstanding scholarship in the fields of immunobiology, molecular biophysics, and cell biology

Home Page

Over 50 Faculty and 30 PhD Students

The Cellular and Molecular Medicine (CMM) and Immunobiology (IMB) graduate programs at the University of Arizona have merged to create the Graduate Program in Molecular Medicine (GPMM). GPMM is an interdepartmental, multidisciplinary training program that fosters the development of scientists and educators who are prepared for lifelong participation in research and other intellectual pursuits. With an emphasis on bridging basic and translational science, Molecular Medicine trainees receive advanced training in the theory and practice of biomedical science. There are opportunities to investigate human health and disease ranging from biophysical studies at the atomic level, to modeling critical cellular process in tractable systems, to clinical research. The exposure and skills that our trainees acquire prepare them for careers in biomedical research (including academia and the biotechnology industry), science education, journalism, and public policy.

Cell Biology

Cell Biology

To provide students with a foundation for understanding the cellular underpinnings of human health and disease, while advancing the field through hands-on, cutting-edge research.

Medical Biophysics

Medical Biophysics

Apply quantitative multi-disciplinary approaches to molecular and integrative biology with a goal to understand the biophysical basis of health and disease mechanisms, identify drugable targets and contribute to Precision Medicine.

Immunobiology

Immunobiology

Advance the insights into the rules of engagement that determine the outcome of host-pathogen interactions to develop future therapies for infectious, autoimmune and malignant diseases.

News

How 'autoantibodies' could help us understand long COVID and other autoimmune diseases

Michael Kuhns, an associate professor of immunobiology at the University of Arizona who was not affiliated with the ASU study, said that having a better handle on what kinds of autoantibodies exist in healthy people may help scientists evaluate "how robust (a particular autoantibody) might be as a biomarker, even a diagnostic.”


AZ HEROES Research Study Awarded $22M to Continue Evaluation of COVID-19 Immunity, Vaccine Effectiveness

CDC funding will allow research on COVID-19 immunity and vaccine effectiveness to continue as new variants emerge.


Maggert Lab Discovers DNA Instability That May Lead to Cancer

Keith Maggert, PhD, along with his former graduate student, Farah Bughio, PhD, discovered that a form of DNA called heterochromatin is unstable and can result in genetic mutations which increase the chances of developing cancer.